Neill Liptrott

Dr Liptrott has a background in pharmacology, immunology and molecular cell biology. His research is focused on investigating biocompatibility, immunocompatibility and haematocompatibility of conventional and nanotechnology-enabled medicines. Dr Liptrott is a member of the Executive Board, as well as core expert team (CET), of the European Nanomedicine Characterisation Laboratory (EU-NCL; http://www.euncl.eu/) for nanoparticle biocompatibility and structure-activity relationships.